A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients' Lives and Allografts
- PMID: 32947798
- PMCID: PMC7563559
- DOI: 10.3390/jcm9092986
A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients' Lives and Allografts
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has posed a significant challenge to physicians and healthcare systems worldwide. Evidence about kidney transplant (KTx) recipients is still limited. A systematic literature review was performed. We included 63 articles published from 1 January until 7 July 2020, reporting on 420 adult KTx recipients with confirmed COVID-19. The mean age of patients was 55 ± 15 years. There was a male predominance (67%). The majority (74%) were deceased donor recipients, and 23% were recently transplanted (<1 year). Most patients (88%) had at least one comorbidity, 29% had two, and 18% three. Ninety-three percent of cases were hospitalized. Among them, 30% were admitted to the intensive care unit, 45% developed acute respiratory distress syndrome, and 44% had acute kidney injury with 23% needing renal replacement therapy. From the hospitalized patients a total of 22% died, 59% were discharged, and 19% were still in hospital at the time of publication. Immunosuppression was reduced in 27%, discontinued in 31%, and remained unchanged in 5%. Hydroxychloroquine was administered to 78% of patients, antibiotics to 73%, and antivirals to 30% while 25% received corticosteroid boluses, 28% received anti-interleukin agents, and 8% were given immunoglobulin. The main finding of our analysis was that the incidence of COVID-19 among kidney transplant patients is not particularly high, but when they do get infected, this is related to significant morbidity and mortality.
Keywords: COVID-19 infection; immunosuppression; kidney transplantation; outcomes; treatment.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
COVID-19 in Liver Transplant Recipients.J Clin Transl Hepatol. 2021 Aug 28;9(4):545-550. doi: 10.14218/JCTH.2020.00098. Epub 2021 Feb 22. J Clin Transl Hepatol. 2021. PMID: 34447684 Free PMC article.
-
A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.Transplantation. 2012 Oct 15;94(7):671-8. doi: 10.1097/TP.0b013e318264fbc1. Transplantation. 2012. PMID: 22948444
-
Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.Cureus. 2020 Sep 29;12(9):e10716. doi: 10.7759/cureus.10716. Cureus. 2020. PMID: 33033687 Free PMC article.
-
The Dilemma of Renal Involvement in COVID-19: A Systematic Review.Cureus. 2020 Jun 15;12(6):e8632. doi: 10.7759/cureus.8632. Cureus. 2020. PMID: 32685301 Free PMC article. Review.
-
Incidence of Mortality, Acute Kidney Injury and Graft Loss in Adult Kidney Transplant Recipients with Coronavirus Disease 2019: Systematic Review and Meta-Analysis.J Clin Med. 2021 Nov 4;10(21):5162. doi: 10.3390/jcm10215162. J Clin Med. 2021. PMID: 34768682 Free PMC article. Review.
Cited by
-
Characteristics of COVID-19 Disease in Renal Transplant Recipients.Medicina (Kaunas). 2024 Jan 24;60(2):201. doi: 10.3390/medicina60020201. Medicina (Kaunas). 2024. PMID: 38399489 Free PMC article.
-
Assessment of mRNA Vaccine Immunogenicity in Solid Organ Transplant Recipients.Medicina (Kaunas). 2023 Jun 2;59(6):1075. doi: 10.3390/medicina59061075. Medicina (Kaunas). 2023. PMID: 37374279 Free PMC article.
-
Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection.Microorganisms. 2023 Feb 28;11(3):612. doi: 10.3390/microorganisms11030612. Microorganisms. 2023. PMID: 36985188 Free PMC article. Review.
-
Transplantation Amid a Pandemic: The Fall and Rise of Kidney Transplantation in the United States.Transplant Direct. 2022 Dec 12;9(1):e1423. doi: 10.1097/TXD.0000000000001423. eCollection 2023 Jan. Transplant Direct. 2022. PMID: 36582674 Free PMC article.
-
Cardiovascular Complications in Kidney Transplant Recipients with COVID-19: A Case Series.Indian J Nephrol. 2022 Sep-Oct;32(5):506-511. doi: 10.4103/ijn.ijn_503_21. Epub 2022 Jul 2. Indian J Nephrol. 2022. PMID: 36568602 Free PMC article.
References
-
- Centers for Disease Control and Prevention People with Underlying Medical Conditions, Immunocompromised State (Weakened Immune System) from Solid Organ Transplant. [(accessed on 30 July 2020)];2020 Available online: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-....
-
- Pereira M.R., Mohan S., Cohen D.J., Husain S.A., Dube G.K., Ratner L.E., Arcasoy S., Aversa M.M., Benvenuto L.J., Dadhania D.M., et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am. J. Transpl. 2020;20:1800–1808. doi: 10.1111/ajt.15941. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources